Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Saturday Links

Posted on June 29, 2024June 28, 2024 by John C. Goodman
  • What happens when whistleblowers reveal what appears to be medical malpractice associated with “gender affirming care”?  The government goes after the whistleblowers.
  • More on AI and rural health. (STAT)
  • New NBER paper: “Our calculations indicate that currently proposed U.S. policies to reduce pharmaceutical prices, though particularly beneficial for low-income and elderly populations, could dramatically reduce firms’ investment in highly welfare-improving R&D.”
  • Could quitting your job actually help the economy?
  • Steuerle: “Never in U.S. history has there been so much growth in debt scheduled in current law from past legislation.”
  • BMJ publication bias during covid: very one-sided and on the wrong side of history.
  • Feds seek delay in releasing covid safety data.
  • Do good-looking people live longer? 
+

Friday Links

Posted on June 28, 2024June 27, 2024 by John C. Goodman
  • New study: the relationship between freedom and economic prosperity is stronger than previously thought.
  • David Friedman: Why Chicago economics is better than Austrian economics.
  • Does weed cause strokes and heart attacks? Apparently not. We linked to the original study, but this video convinced me that it was junk science.
  • Milliman study: Medicare Part D drug price negotiation program could raise out-of-pocket costs in 2026 for 3.5 million seniors.
  •  Cato: “Our results suggest that the costs of menthol prohibition to users and suppliers exceed the value of the reduction in mortality risks from secondhand smoke by $15.4 billion.”
  • Paragon: 5 million people have been fraudulently enrolled in the Obamacare exchanges costing taxpayers an estimated $20 billion this year.
+

WSJ: PBMs Charge More for Mail-Order Drugs Than Prices at Local Pharmacies

Posted on June 28, 2024June 27, 2024 by Devon Herrick

Some seniors order drugs from abroad to save money. A few states are even considering mail-ordering cheaper drugs from Canada for state employees. Every employer cannot order drugs from Canada, however. There are just not enough drugs in Canada to serve their own population along with 100 million Americans with employee health coverage.

+

Wednesday Links

Posted on June 26, 2024June 25, 2024 by John C. Goodman
  • Study: Bans on flavored tobacco products don’t work.
  • Are women taking over our health care system?
    • There are 4.2 million nurses, over 1 million doctors, and over 1/2 million PAs and NPs in the US…. Women hold … 90% of all nursing positions, 66% of PAs, and 55% of all current Medical School slots.

  • NBER study: As hospital prices went up 1%, the percentage of people who ended up out of a job rose by 0.4% and payments for tax-funded unemployment insurance increased 2.5%. 
  • The total expense [of developing a new drug] is estimated at $1 billion on average. It takes 10 to 15 years. And nearly 90 percent of the candidate drugs that enter human clinical trials fail.
  • Colorado wants to import drugs from Canada. Pharma is opposed.
+
  • Previous
  • 1
  • …
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 223
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom